Emma Shanks - Concepedia

Author

Emma Shanks

Cancer Research UK Scotland Institute ORCID

Also Known As

Alan Ashworth, Chidochangu P. Mpamhanga, E. Shanks, Emma J. Shanks, Emma Shanks, Emma J. Shanks, Shanks, Emma, Susanna L. Cooke

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Cancer Research UK Scotland Institute University of Glasgow University of Dundee Imperial College London The Francis Crick Institute

About

Emma Shanks is an author at Cancer Research UK Scotland Institute specializing in medicine, natural sciences, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	832
2	Natural Sciences	3	3	237
3	Biochemistry	3	3	237
4	Cell Biology	2	2	299
5	Engineering	1	1	296

Emma Shanks

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic Stress Zachary T. Schug, Barrie Peck, Dylan T. Jones, Cancer Cell	2015	796
Predicting Cancer-Specific Vulnerability via Data-Driven Detection of Synthetic Lethality Livnat Jerby‐Arnon, Nadja Pfetzer, Yedael Y. Waldman, Cell EngineeringPredictive ToxicologyMedicineComputational BiologySynthetic Lethality	2014	296
Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments Barrie Peck, Zachary T. Schug, Beatrice Dankworth, Cancer & Metabolism	2016	261
Targeting the <scp>LOX</scp> / <scp>hypoxia</scp> axis reverses many of the features that make pancreatic cancer deadly: inhibition of <scp>LOX</scp> abrogates metastasis and enhances drug efficacy Bryan W. Miller, Jennifer P. Morton, Mark Pinese, EMBO Molecular Medicine Tumor BiologyOncologyPancreatic CancerGastrointestinal OncologyMedicine	2015	259
Harnessing synthetic lethality to predict the response to cancer treatment Joo Sang Lee, Avinash Das, Livnat Jerby‐Arnon, Nature Communications	2018	139
Dihydroquinazolines as a Novel Class of Trypanosoma brucei Trypanothione Reductase Inhibitors: Discovery, Synthesis, and Characterization of their Binding Mode by Protein Crystallography Stephen Patterson, M.S. Alphey, Deuan C. Jones, Journal of Medicinal Chemistry Protein CrystallographyBioorganic ChemistryAntiparasitic AgentNew SubpocketChemical Biology	2011	130
Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition Rebecca Mitchell, Lisa Hopcroft, Pablo Baquero, JNCI Journal of the National Cancer Institute	2017	130
One Scaffold, Three Binding Modes: Novel and Selective Pteridine Reductase 1 Inhibitors Derived from Fragment Hits Discovered by Virtual Screening Chidochangu P. Mpamhanga, Daniel Spinks, L.B. Tulloch, Journal of Medicinal Chemistry	2009	105
The phospholipid PI(3,4)P2 is an apical identity determinant Álvaro Román‐Fernández, Julie Roignot, Emma Sandilands, Nature Communications	2018	83
Investigation of Trypanothione Reductase as a Drug Target in <i>Trypanosoma brucei</i> Daniel Spinks, Emma Shanks, Laura A. T. Cleghorn, ChemMedChem Drug TargetBioorganic ChemistryT. Brucei TryrAntiparasitic AgentMalaria	2009	57

Page 1